Search hospitals > Florida > Fort Myers
Florida Cancer Specialists
Claim this profileFort Myers, Florida 33901
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
Conducts research for Tumors
184 reported clinical trials
10 medical researchers
Summary
Florida Cancer Specialists is a medical facility located in Fort Myers, Florida. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Cancer, Tumors and other specialties. Florida Cancer Specialists is involved with conducting 184 clinical trials across 108 conditions. There are 10 research doctors associated with this hospital, such as Fadi Kayali, MD, Ivor J Percent, Lowell L Hart, and Vance M. Wright-Browne.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
BRAF positive
2Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
Top PIs
Fadi Kayali, MDFlorida Cancer Specialists South / Sarah Cannon Research Institute4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
13 reported clinical trials
38 drugs studied
Ivor J PercentFlorida Cancer Specialists & Research Institute6 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
6 reported clinical trials
12 drugs studied
Lowell L HartWake Forest Baptist Medical Center / Wake Forest University4 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Breast Cancer
6 reported clinical trials
15 drugs studied
Vance M. Wright-BrowneFlorida Cancer Specialists4 years of reported clinical research
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
11 drugs studied
Clinical Trials running at Florida Cancer Specialists
Breast Cancer
Lymphoma
Non-Small Cell Lung Cancer
Cancer
Follicular Lymphoma
Leukemia
B-Cell Leukemia
Lymphoid Leukemia
Chronic B-Cell Leukemia
Chronic Lymphocytic Leukemia
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) versus treatment of physician's choice (TPC) in participants with previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do not express programmed cell death ligand 1 (PD-L1) or in participants previously treated with anti-programmed cell death (ligand or protein) 1 (Anti-PD-(L)1) Agents in the early setting whose tumors do express PD-L1.
Recruiting4 awards Phase 3
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) and pembrolizumab versus treatment of physician's choice (TPC) and pembrolizumab in participants with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors express programmed cell death ligand 1 (PD-L1).
Recruiting4 awards Phase 3
Imlunestrant + Abemaciclib
for Breast Cancer
This study is evaluating whether a drug called LY3484356 can help treat breast cancer.
Recruiting2 awards Phase 39 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Florida Cancer Specialists?
Florida Cancer Specialists is a medical facility located in Fort Myers, Florida. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Cancer, Tumors and other specialties. Florida Cancer Specialists is involved with conducting 184 clinical trials across 108 conditions. There are 10 research doctors associated with this hospital, such as Fadi Kayali, MD, Ivor J Percent, Lowell L Hart, and Vance M. Wright-Browne.